Economic evaluation of different haematological monitoring schemes for patients with treatment-resistant schizophrenia using clozapine
A revision of current UK clozapine monitoring practice would be beneficial from both a clinical and an economic perspective. Adjusting ANC criteria for clozapine cessation avoids unnecessary early discontinuation of clozapine treatment and has a positive impact on quality of life. An extension of monitoring intervals reduces costs borne by the healthcare system. Safety is not compromised by these changes.
Authors
- David Taylor (ORCID: https://orcid.org/0000-0002-2557-1710)
- Christian Bachmann (ORCID: https://orcid.org/0000-0001-7526-2660)
- Ebenezer Oloyede (ORCID: https://orcid.org/0000-0003-1352-4017)
- Freya Diederich (ORCID: https://orcid.org/0000-0001-9146-6452)
Institutions
- University of Bremen (DE)
- King's College London (GB)
- Universität Ulm (DE)
- University of Oxford (GB)
- Maudsley Hospital (GB)
- University Hospital Ulm (DE)
- Technische Hochschule Ulm (DE)
Publication Details
- Journal
- The British Journal of Psychiatry
- Published
- 2025-11-13
- DOI
- https://doi.org/10.1192/bjp.2025.10424
- Citations
- 1
- Primary Topic
- Schizophrenia research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.47